Researchmoz added Most up-to-date research on "Global CAR T-Cell Therapy for Multiple Myeloma Market Size, Status and Forecast 2025" to its huge collection of research reports.
This report studies the global CAR T-Cell Therapy for Multiple Myeloma market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global CAR T-Cell Therapy for Multiple Myeloma market by companies, region, type and end-use industry.
CARs are also known as chimeric immunoreceptors, chimeric T-cell receptors, artificial T-cell receptors or CAR T. they are used as an individual's own cells and re-engineers them to fight cancer. Though the market has witnessed several positive results of the clinical trial in the recent years, it is yet to receive an approval of the first CAR T-cell therapy formultiple myeloma.
The increasing number of collaborations or licensing agreements between companies and research institute, will induce the involvement of more investors in this area. Car T-cell therapy for multiple myeloma has identified that most of the pipeline molecules in multiple myeloma are currently in the pre-clinical development stage. KMA.CAR-T the drug is under development by the company HaemaLogiX. This monotherapy drug is currently in the pre-clinical stage and the company has already signed an agreement with Westmead Institute for Medical Research.
In 2017, the global CAR T-Cell Therapy for Multiple Myeloma market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.
To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1861080
This report focuses on the global top players, covered
Juno Therapeutics
Kite Pharma
Novartis
Collectis
...
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Market segment by Type, the product can be split into
Monotherapy
Combination Therapy
Market segment by Application, split into
Multiple Myeloma
Refractory or Relapsed Multiple Myeloma
The study objectives of this report are:
To study and forecast the market size of CAR T-Cell Therapy for Multiple Myeloma in global market.
To analyze the global key players, SWOT analysis, value and global market share for top players.
To define, describe and forecast the market by type, end use and region.
To analyze and compare the market status and forecast between China and major regions, namely, United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of CAR T-Cell Therapy for Multiple Myeloma are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
CAR T-Cell Therapy for Multiple Myeloma Manufacturers
CAR T-Cell Therapy for Multiple Myeloma Distributors/Traders/Wholesalers
CAR T-Cell Therapy for Multiple Myeloma Subcomponent Manufacturers
Industry Association
Downstream Vendors
Table of Contents
Global CAR T-Cell Therapy for Multiple Myeloma Market Size, Status and Forecast 2025
1 Industry Overview of CAR T-Cell Therapy for Multiple Myeloma
1.1 CAR T-Cell Therapy for Multiple Myeloma Market Overview
1.1.1 CAR T-Cell Therapy for Multiple Myeloma Product Scope
1.1.2 Market Status and Outlook
1.2 Global CAR T-Cell Therapy for Multiple Myeloma Market Size and Analysis by Regions (2013-2018)
1.2.1 United States
1.2.2 Europe
1.2.3 China
1.2.4 Japan
1.2.5 Southeast Asia
1.2.6 India
1.3 CAR T-Cell Therapy for Multiple Myeloma Market by Type
1.3.1 Monotherapy
1.3.2 Combination Therapy
1.4 CAR T-Cell Therapy for Multiple Myeloma Market by End Users/Application
1.4.1 Multiple Myeloma
1.4.2 Refractory or Relapsed Multiple Myeloma
2 Global CAR T-Cell Therapy for Multiple Myeloma Competition Analysis by Players
2.1 CAR T-Cell Therapy for Multiple Myeloma Market Size (Value) by Players (2013-2018)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 Company (Top Players) Profiles
3.1 Juno Therapeutics
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 CAR T-Cell Therapy for Multiple Myeloma Revenue (Million USD) (2013-2018)
3.2 Kite Pharma
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 CAR T-Cell Therapy for Multiple Myeloma Revenue (Million USD) (2013-2018)
3.3 Novartis
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 CAR T-Cell Therapy for Multiple Myeloma Revenue (Million USD) (2013-2018)
3.4 Collectis
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 CAR T-Cell Therapy for Multiple Myeloma Revenue (Million USD) (2013-2018)
Get Complete TOC With Tables and Figures @ https://www.researchmoz.us/global-car-t-cell-therapy-for-multiple-myeloma-market-size-status-and-forecast-2025-report.html/toc
4 Global CAR T-Cell Therapy for Multiple Myeloma Market Size by Type and Application (2013-2018)
4.1 Global CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2013-2018)
4.2 Global CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2013-2018)
4.3 Potential Application of CAR T-Cell Therapy for Multiple Myeloma in Future
4.4 Top Consumer/End Users of CAR T-Cell Therapy for Multiple Myeloma
5 United States CAR T-Cell Therapy for Multiple Myeloma Development Status and Outlook
5.1 United States CAR T-Cell Therapy for Multiple Myeloma Market Size (2013-2018)
5.2 United States CAR T-Cell Therapy for Multiple Myeloma Market Size and Market Share by Players (2013-2018)
5.3 United States CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2013-2018)
6 Europe CAR T-Cell Therapy for Multiple Myeloma Development Status and Outlook
6.1 Europe CAR T-Cell Therapy for Multiple Myeloma Market Size (2013-2018)
6.2 Europe CAR T-Cell Therapy for Multiple Myeloma Market Size and Market Share by Players (2013-2018)
6.3 Europe CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2013-2018)
Continue...
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on @ https://marketsizeinfo.blogspot.in/